Ads
related to: breast cancer drug- Overall Survival Results
See Updated Overall Survival Data
For This Treatment Option
- Dosing & Administration
Read More About Dosing
And How To Prescribe
- Patient Support
View The The Service Request Form
To Gain Access To Support Programs
- Safety Profile
View The Full Safety Profile And
See Side Effects For This Option
- Financial Resources
Learn About The Available Access
Programs For Your Patients
- Official Video Library
See A Medical Expert Discuss
Overall Survival Data For mBC
- Overall Survival Results
Search results
AstraZeneca, Daiichi look to broaden Enhertu use again with new study data
BioPharma Dive via Yahoo Finance· 7 hours agoThe drug benefited people whose tumors have “ultralow” levels of HER2 protein, a result that could...
Cancer Drugs: Strategies For Patenting Antibody-Drug Conjugate Inventions
The National Law Review· 2 hours agoAntibody-drug conjugate (ADC) is a promising class of cancer treatments with accelerating U.S. Food...
Here’s How Breast-Cancer Treatments Have Changed For The Better
Women's Health via Yahoo News· 3 days agocancers, or had their cancers shrink when their ovaries were removed. “At that time, there were no...
The aspirin conundrum: Navigating negative results, age, aging dynamics and equity
Medical Xpress· 3 hours agoA new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications ...
Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena via Yahoo Finance· 10 hours agoThe drug’s PTSR decreased by 11 points to 34% in bile duct cancer, 10 points to 35% in gallbladder ...
Europe Recommends Three Cancer Drugs
Medscape· 4 days agoThe European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.
Researchers identify novel gene networks associated with aggressive type of breast cancer
Medical Xpress· 5 days agoRecently, scientists in the Georgia Tech Integrated Cancer Research Center (ICRC) have found that this particular breast cancer displays ...
Treatment Options for HER2-Negative Breast Cancer
Healthline· 5 days agoMost breast cancers are HER2-negative. There are many treatment options for this type of breast cancer. Your treatment ...
...BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of HERCESSI™...Several Forms...
WKBN 27 Youngstown· 6 hours agoFood and Drug Administration (FDA) has approved HERCESSI™ (trastuzumab-strf), a biosimilar to Herceptin® (trastuzumab), to treat HER2-overexpressing breast
Blocking Gene May Halt Growth of Some Breast Cancers
Technology Networks· 4 days agoShutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to...
Ads
related to: breast cancer drug